Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 19Unknown 9Recruiting 6Terminated 4Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 186Carcinoma, Non-Small-Cell Lung 144Multiple Myeloma 120Prostatic Neoplasms 118Leukemia, Myeloid, Acute 77Neoplasms 75Colorectal Neoplasms 75Melanoma 72Neoplasm Metastasis 66Lymphoma 66Squamous Cell Carcinoma of Head and Neck 64Lung Neoplasms 64Pancreatic Neoplasms 54Ovarian Neoplasms 50Sarcoma 46Carcinoma, Renal Cell 45Triple Negative Breast Neoplasms 43Glioblastoma 42Urinary Bladder Neoplasms 41Leukemia, Lymphocytic, Chronic, B-Cell 41Carcinoma, Hepatocellular 41Recurrence 40Head and Neck Neoplasms 38Hematologic Neoplasms 37Lymphoma, Large B-Cell, Diffuse 36Precursor Cell Lymphoblastic Leukemia-Lymphoma 35Myelodysplastic Syndromes 35Lymphoma, Non-Hodgkin 34Brain Neoplasms 34Lymphoma, Mantle-Cell 31

Interventions

Dexamethasone 1Calcium Dobesilate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Active not recruiting × Nausea × Clear all
NCT00489307 2025-11-12

Dexamethasone for Symptom Burden in Advanced Cancer Patients

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
132 enrolled 15 charts

Anorexia, Fatigue, Nausea, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡